Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
Status:
Completed
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn more about the characteristics of CLL,
including genes and chromosome abnormalities and proteins expressed by the leukemia cells,
which may help doctors predict if patients who receive standard treatment (fludarabine,
cyclophosphamide, and rituximab) for the first time will experience a complete remission.